SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward

Author:

ISERSON KENNETH V.

Abstract

AbstractThe world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to “normal.” Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern is the potential danger to the health of human test subjects and, eventually, many vaccine recipients. This is further complicated by economic and political pressures to reduce government oversight on rushed vaccine testing and production, nationalistic distribution goals, and failure to plan for the widespread immunization needed to produce global herd immunity. As this paper asserts, the public must be better informed to assess promises about the novel vaccines being produced and to tolerate delays and uncertainty.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,Issues, ethics and legal aspects,Health(social science)

Reference38 articles.

1. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route

2. 28. See note 18, Jamrozik, Selgelid 2020.

3. 9. Biotechnology Innovation Organization, Biomedtracker, Amplion. As cited in: Thompson SA. How long will a vaccine really take? Available at https://www.nytimes.com/interactive/2020/04/30/opinion/coronavirus-covid-vaccine.html?campaign_id=57&emc=edit_ne_20200430&instance_id=18115&nl=evening-briefing®i_id=88426177&segment_id=26333&te=1&user_id=698624f6bce25e600ce6522455a17609 (last accessed 30 Apr 2020).

4. The Equitable Distribution of COVID-19 Therapeutics and Vaccines

5. Ethics and etiquette in an emergency vaccine trial. The orchestration of compliance

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3